Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh; Ying Chin Lin; Wei Jen Chen; Chao Yuan Huang; Horng Sheng Shiue; Yeong Shiau Pu; Chi Hung Chen; Chien Tien Su

doi:10.1016/j.taap.2018.07.022

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Yu Mei Hsueh
, Ying Chin Lin
, Wei Jen Chen
, Chao Yuan Huang
, Horng Sheng Shiue
, Yeong Shiau Pu
, Chi Hung Chen
, Chien Tien Su^*

^*Corresponding author for this work

School of Traditional Chinese Medicine

Taipei Medical University
National Taiwan University

Research output: Contribution to journal › Comment/debate

Abstract

Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “ ^e ” of Dr. Ying-Chin Lin, which was incorrectly given as. “ ^e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “ ^e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

Original language	English
Pages (from-to)	139
Number of pages	1
Journal	Toxicology and Applied Pharmacology
Volume	356
DOIs	https://doi.org/10.1016/j.taap.2018.07.022
State	Published - 01 10 2018

Bibliographical note

Publisher Copyright:
© 2018 Elsevier Inc.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.taap.2018.07.022

Fingerprint

Dive into the research topics of 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))'. Together they form a unique fingerprint.

Cite this

Hsueh, Y. M., Lin, Y. C., Chen, W. J., Huang, C. Y., Shiue, H. S., Pu, Y. S., Chen, C. H., & Su, C. T. (2018). Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). Toxicology and Applied Pharmacology, 356, 139. https://doi.org/10.1016/j.taap.2018.07.022

@article{43d8e26085e747e3ab3e6dc9413f15db,

title = "Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))",

abstract = " Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “ e ” of Dr. Ying-Chin Lin, which was incorrectly given as. “ e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “ e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”",

author = "Hsueh, \{Yu Mei\} and Lin, \{Ying Chin\} and Chen, \{Wei Jen\} and Huang, \{Chao Yuan\} and Shiue, \{Horng Sheng\} and Pu, \{Yeong Shiau\} and Chen, \{Chi Hung\} and Su, \{Chien Tien\}",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = oct,

day = "1",

doi = "10.1016/j.taap.2018.07.022",

language = "英语",

volume = "356",

pages = "139",

journal = "Toxicology and Applied Pharmacology",

issn = "0041-008X",

publisher = "Academic Press Inc.",

}

Hsueh, YM, Lin, YC, Chen, WJ, Huang, CY, Shiue, HS, Pu, YS, Chen, CH & Su, CT 2018, 'Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))', Toxicology and Applied Pharmacology, vol. 356, pp. 139. https://doi.org/10.1016/j.taap.2018.07.022

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). / Hsueh, Yu Mei; Lin, Ying Chin; Chen, Wei Jen et al.
In: Toxicology and Applied Pharmacology, Vol. 356, 01.10.2018, p. 139.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

AU - Hsueh, Yu Mei

AU - Lin, Ying Chin

AU - Chen, Wei Jen

AU - Huang, Chao Yuan

AU - Shiue, Horng Sheng

AU - Pu, Yeong Shiau

AU - Chen, Chi Hung

AU - Su, Chien Tien

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “ e ” of Dr. Ying-Chin Lin, which was incorrectly given as. “ e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “ e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

AB - Because of our mistakes, we hope we can have the opportunity to make corrections, do not affect Dr. Lin's promotion. Affiliation “ e ” of Dr. Ying-Chin Lin, which was incorrectly given as. “ e Division of Family Medicine, School of Medicine, Taipei Medical University, Taipei, Taiwan”. The correct affiliation of Dr. Lin is listed below: “ e Department of Family Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.”

UR - https://www.scopus.com/pages/publications/85051638573

U2 - 10.1016/j.taap.2018.07.022

DO - 10.1016/j.taap.2018.07.022

M3 - 评论/辩论

C2 - 30048668

AN - SCOPUS:85051638573

SN - 0041-008X

VL - 356

SP - 139

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

ER -

Hsueh YM, Lin YC, Chen WJ, Huang CY, Shiue HS, Pu YS et al. Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)). Toxicology and Applied Pharmacology. 2018 Oct 1;356:139. doi: 10.1016/j.taap.2018.07.022

Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012))

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this